These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 15145167)
1. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate. Nijdam W; Levendag P; Noever I; Uyl-de Groot C; van Agthoven M Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):488-94. PubMed ID: 15145167 [TBL] [Abstract][Full Text] [Related]
2. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing? Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475 [TBL] [Abstract][Full Text] [Related]
3. Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications. Nijdam W; Levendag P; Noever I; Groot CU; Agthoven Mv Radiother Oncol; 2005 Oct; 77(1):65-72. PubMed ID: 16213619 [TBL] [Abstract][Full Text] [Related]
4. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy. Andrews SF; Anderson PR; Eisenberg BL; Hanlon AL; Pollack A Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):475-80. PubMed ID: 15145165 [TBL] [Abstract][Full Text] [Related]
5. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue. van de Pol M; Levendag PC; de Bree RR; Franssen JH; Smeele LE; Nijdam WM; Jansen PP; Meeuwis CA; Leemans CR Brachytherapy; 2004; 3(2):78-86. PubMed ID: 15374539 [TBL] [Abstract][Full Text] [Related]
7. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity. Alektiar KM; Brennan MF; Singer S Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone. Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848 [TBL] [Abstract][Full Text] [Related]
10. Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients. Le Scodan R; Pommier P; Ardiet JM; Montbarbon X; Malet C; Favrel V; Zrounba P; Poupart M; Céruse P; Ferlay C; Clippe S Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):441-8. PubMed ID: 16168837 [TBL] [Abstract][Full Text] [Related]
11. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175 [TBL] [Abstract][Full Text] [Related]
12. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma. Zheng XK; Chen LH; Chen YQ; Deng XG Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552 [TBL] [Abstract][Full Text] [Related]
13. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma. Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V J BUON; 2007; 12(2):221-6. PubMed ID: 17600876 [TBL] [Abstract][Full Text] [Related]
14. [Value of the combination of external radiotherapy and curietherapy in carcinoma of the velo-tonsillar region. Statistical study of a series of 361 patients]. Pernot M; Hoffstetter S; Malissard L; Luporsi E; Peiffert D; Aletti P; Marchal C; Kozminski P; Bey P Bull Cancer Radiother; 1996; 83(1):40-6. PubMed ID: 8679280 [TBL] [Abstract][Full Text] [Related]
15. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis. Rossi PJ; Jani AB; Horowitz IR; Johnstone PA Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014 [TBL] [Abstract][Full Text] [Related]
17. Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer. Do L; Puthawala A; Syed N Brachytherapy; 2009; 8(4):385-91. PubMed ID: 19733128 [TBL] [Abstract][Full Text] [Related]